Unicon Sciences

Executive Summary

Unicon Sciences is a US-based life sciences consulting firm that provides strategic services to pharmaceutical, biotechnology, and medical device companies. Founded in 2017 and headquartered in San Diego, the company focuses on accelerating drug discovery, improving clinical trial efficiencies, and enhancing manufacturing productivity. Its core expertise spans pharmacovigilance, regulatory affairs, compliance, and validation. By building trusted client relationships and delivering best-in-class solutions, Unicon Sciences aims to improve patient health outcomes. The firm operates in the diagnostics and proteomics categories, offering a specialized niche in a growing market driven by increasing regulatory complexity and the need for efficient drug development. As a private company with no disclosed funding or valuation, Unicon Sciences maintains a lean operational model focused on service excellence.

Upcoming Catalysts (preview)

• Q3 2026Major Contract Win with Top-20 Pharma70% success
• Q1 2027Expansion into European Regulatory Consulting50% success
• Q2 2026Partnership with CRO for Integrated Services65% success